GenoFocus Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Eui-Joong Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership9.8%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Is GenoFocus (KOSDAQ:187420) A Risky Investment?

Apr 13
Is GenoFocus (KOSDAQ:187420) A Risky Investment?

Can You Imagine How GenoFocus' (KOSDAQ:187420) Shareholders Feel About The 55% Share Price Increase?

Feb 16
Can You Imagine How GenoFocus' (KOSDAQ:187420) Shareholders Feel About The 55% Share Price Increase?

Is GenoFocus (KOSDAQ:187420) A Risky Investment?

Dec 22
Is GenoFocus (KOSDAQ:187420) A Risky Investment?

CEO

Eui-Joong Kim

no data

Tenure

Eui-Joong Kim serves as the Chief Executive Officer of Geno Focus, Inc. Eui-Joong Kim served as President of the Research Group at Korea Biotechnology Industry. Eui-Joong Kim is Adjunct Professor of System...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.